Completed NA INTERVENTIONAL 1-arm NCT01946009

A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients (CIDAN12)

Sponsor: Fundacion SEIMC-GESIDA

Conditions HIV

Interventions Cidofovir 1% cream's basis, 2gr, three times per week, during 4 weeks.

Updated 5 times since 2017 Last updated: Jun 28, 2016 Started: Sep 30, 2013 Primary completion: Sep 30, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01946009, this NA trial focuses on HIV and remains completed. Sponsored by Fundacion SEIMC-GESIDA, it has been updated 5 times since 2013, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundacion SEIMC-GESIDA

Data source: Fundacion SEIMC-GESIDA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain